Cardiff Oncology Stock Discussion

$Cardiff Oncology (CRDF.US)$ Reuters· 2 mins ago
Cardiff Oncology Inc: Announces New Patent With Claims for Use of Onvansertib in Treating Kras Mutated Mcrc

$Cardiff Oncology (CRDF.US)$ first 🎯6.63 🚀

$Cardiff Oncology (CRDF.US)$
Risk Assessment
CRDF is assessed as a high-risk investment with a risk level score of 8/10. This elevated risk stems from the company's negative financial position, large operating losses, and heavy reliance on equity financing, which could lead to volatility and rapid changes in stock price. The Biotechnology sector's low appeal further contributes to the stock's risk, limiting investor interest. Short interest is high, suggesting a significant portion of investors ...

$Cardiff Oncology (CRDF.US)$ + (HOLO-LYT-PIXY...) KEEP BUYING, THEN THEY MUST GO DOWN (TO $1  AND DELETE) BECAUSE CHEATERS BLOCK SHORT = LAO TRAP TRADERS ONE WAY TO HELL 😭👹😡👊👎

$Cardiff Oncology (CRDF.US)$ back again in my 👀 testing 4.50

$Cardiff Oncology (CRDF.US)$ changed my mindset , protecting money intelligently ! out from here smallest gains mattters then home run 🤘🏻
🤘🏻